Ron Leuty
@SFBIZronleuty
Followers
847
Following
223
Statuses
4K
Biotech (@rleuty_biotech) and sports business (@rleutySportsBiz) reporter @SFBusinessTimes Tip me on the Signal messaging app at 415-722-2678.
San Francisco Bay Area
Joined December 2012
RT @rleuty_biotech: 7 questions for Brigette Renee LeBlanc, the first woman president of the San Francisco African American Chamber of Comm…
0
1
0
OpenAI, Waymo, Visa play into Bay Area plans for Super Bowl LX - San Francisco Business Times via @SFBusinessTimes
0
1
0
RT @rleuty_biotech: Former @NFL players, med-tech company HeartFlow team with Denver institute on cardiovascular risk study
0
2
0
RT @rleuty_biotech: Drug developer Alumis to merge with SoCal's Acelyrin, extend cash, line up psoriasis drug for late-stage readout $ALMS…
0
1
0
RT @rleuty_biotech: 23andMe's Anne Wojcicki open (again) to third-party buyout - San Francisco Business Times via @…
0
1
0
RT @rleuty_biotech: St. Anthony Foundation's new CMO talks nonprofit's role in homelessness, health care "We can look at the problem and se…
0
1
0
RT @rleuty_biotech: @GladstoneInst weighs buying 100,000+ sf to expand in Mission Bay* * There's a big caveat via…
0
1
0
RT @BBGreatMoments: Rickey Henderson’s last moment on a baseball field was catching the ceremonial first pitch thrown by his daughter. http…
0
356
0
RT @rleuty_biotech: Genentech wins 2nd FDA approval for eye-focused Susvimo, this time for a diabetic eye disease v…
0
2
0
RT @rleuty_biotech: As new wave of biotech real estate projects come on line, they're scrambling for tenants via @S…
0
1
0
RT @bizjournals: "Our professional sports in Ohio are very valuable to us. I think it’s part of our quality of life. This gives us an oppor…
0
2
0
RT @SFBusinessTimes: As San Francisco paces tens of thousands of units short of its housing target, Mayor Daniel Lurie says he is focused o…
0
2
0
RT @rleuty_biotech: Chan Zuckerberg Initiative's imaging division inks big Peninsula lease @czi
0
2
0
Cancer cell therapy company Cargo Therapeutics had a big IPO at the end of 2023. Now it's cutting half its workforce after a disappointing clinical trial. via @SFBusinessTimes
0
1
0
RT @rleuty_biotech: New space for @UCSF pediatric pain treatment center speaks to global ambitions for shifting care for kids @ElisaStad h…
0
1
0
RT @rleuty_biotech: 23andMe weighs strategic alternatives, including a possible sale via @SFBusinessTimes
0
1
0
RT @rleuty_biotech: Trump's freeze on NIH grants risks major source of UC, Stanford, biotech startup dollars via @S…
0
1
0